Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

Biomarkers of Alzheimer's disease and mild cognitive impairment: A current perspective

(2015) Piotr Lewczuk et al.   Advances in Medical Sciences

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-  in Cerebrospinal Fluid

(2014) A. Leinenbach et al.   CLINICAL CHEMISTRY

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

(2014) Alberto Lleó et al.   Nature Reviews Neurology

The ISBER Biorepository Proficiency Testing Program: Two Successful Years Already, and New Features to Come

(2013) Fay Betsou et al.   BIOPRESERVATION AND BIOBANKING

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers

(2011) Niklas Mattsson et al.   Alzheimers & Dementia

Bacterial Contamination and the Transport Vial Material Affect Cerebrospinal Fluid Concentrations of β-Amyloid and Tau Protein as Determined by Enzyme Immunoassay

(2011) Kathrin Fronek et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY